skip to main content


Title: A Tale of Drug-Carrier Optimization: Controlling Stimuli Sensitivity via Nanoparticle Hydrophobicity through Drug Loading
Award ID(s):
1610311 2003771 1905818 1629094
NSF-PAR ID:
10204690
Author(s) / Creator(s):
; ; ; ; ; ; ; ;
Date Published:
Journal Name:
Nano Letters
Volume:
20
Issue:
9
ISSN:
1530-6984
Page Range / eLocation ID:
6563 to 6571
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Pharmacoinformatics research has experienced a great deal of successes in detecting drug‐induced adverse events (AEs) using large‐scale health record databases. In the era of polypharmacy, pharmacoinformatics faces many new challenges, and two significant challenges are to detect high‐order drug interactions and to handle strongly correlated drugs. In this article, we propose a super‐combo‐drug test (SupCD‐T) to address the aforementioned two challenges. SupCD‐T detects drug interactions by identifying optimal drug combinations with increased AE risks. In addition, SupCD‐T increases the statistical powers to detect single‐drug effects by combining strongly correlated drugs. Although SupCD‐T does not distinguish single‐drug effects from their combination effects, it is noticeably more powerful in selecting an individual drug effect in the multiple regression analysis, where confounding justification between two correlated drugs reduces the power in testing the individual drug effects on AEs. Our simulation studies demonstrate that SupCD‐T has generally better power comparing with the multiple regression analysis. In addition, SupCD‐T is able to select meaningful drug combinations (eg, highly coprescribed drugs). Using electronic health record database, we illustrate the utility of SupCD‐T and discover a number of drug combinations that have increased risk in myopathy. Some novel drug combinations have not yet been investigated and reported in the pharmacology research.

     
    more » « less